ArticleFrontiers in oncology2025

Comprehensive management of chest wall recurrent HER2-positive breast cancer with Anlotinib and hypofractionated radiotherapy: a case report.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.